Summary. The 
INTRODUCTION
The presence of proteolytic-enzyme inhibitor in human seminal plasma was first demonstrated by Oettlé (1950) , who found that the fibrinolytic activity was suppressed by a heat-stable inhibitor. Several investigations have since confirmed the presence in the semen of such inhibitory factor (s) against seminal fibrinolytic activity (von Kaulla & Shettles, 1953; Rasmussen & Albrechtsen, 1960; Di Bella, Panazzolo & Scarpa, 1966) . Other proteolytic enzymes have also been shown to be sensitive to inhibitors present in ejaculated seminal fluid or in the secretions of male accessory sex glands (Haendle, Fritz, Trautschold & Werle, 1965; Fritz, Trautschold, Haendle & Werle, 1968) . Moreover, the presence of a particular trypsin inhibitor could be demonstrated in bull, guinea-pig, hamster, mouse and rat seminal vesicle secretion as well as in the semen of man, boar and bull. Two different types of trypsin inhibitor were purified from the guinea-pig seminal vesicles. One was capable of inhibiting plasmin in addition to trypsin but both were ineffective against chymotrypsin, kallikrein and thrombin (Fritz, Fink, Meister & Klein, 1970) . On the other hand, an inhibitor could be demonstrated in the bull semen, which was able to inhibit not only trypsin and plasmin but also chymo¬ trypsin and kallikrein.
The seminal trypsin inhibitor can affect the acrosomal trypsin-like activity J. J. 0. Suominen and M. Niemi of bull (von Waldschmidt, Hoffmann & Karg, 1966) , rabbit (Zaneveld, Srivastava & Williams, 1969 , 1970 and human spermatozoa (Suominen, Multamäki & Niemi, 1970) . The trypsin-like enzyme (TLE) in the acrosome is thought to be necessary for removal of the zona pellucida (Yamane, 1935; Stambaugh & Buckley, 1968; Multamäki & Niemi, 1972) . The seminal trypsin inhibitor may therefore be an important factor in the capacitation-decapacitation process (Zaneveld et al., 1969) . In this study, the nature of the trypsin inhibitor complex in human seminal plasma has been further investigated.
MATERIAL AND METHODS

Semen
Human semen samples were obtained from a fertility clinic, rabbit semen was collected by using an artificial vagina and bull semen was kindly supplied by a local breeding unit. Cell-free seminal plasma was produced by centrifugation at 2800 g for 15 min, and was either used for chemical analyses immediately or frozen and stored at -25°C until required.
The TLE of human and bull spermatozoa was prepared as follows (Hartree & Srivastava, 1965) 
Gelfiltration
Sephadex G-75 gel (Pharmacia), particle size 40 to 120 µ , was used ac¬ cording to the manufacturer's instructions. The gel was packed into a column (2· 1x85 cm) and stabilized with normal saline, which was buffered with tris-HCl (5 mmol/litre, pH 7-5 at room temperature). The seminal plasma sample (4-0 ml) was applied on the column, and the elution was carried out with the stabilizing buffer. Fractions (4-0 ml) were collected with a flow rate of 0-1 ml/cm2/min. The trypsin-inhibiting capacity of the fractions was measured, and the active fractions were pooled and concentrated by ultrafiltration.
Utrafiltration
This was performed with Diaflo-apparatus (Amicon N.V.) and the membrane used was UM-2 (molecular exclusion limit, 1000). The pooled fractions were concentrated to a quarter of the original volume.
RESULTS
Experiments with seminal plasma
To determine the trypsin inhibitor content in human, rabbit and bovine seminal plasma, the samples were diluted with saline solution to 1:25, 1:50 and J. J. (Wu & Laskowski, 1955; Walton, 1967 The extent of inhibition is given as a percentage from the uninhibited value.
in the acrosomal preparation. Preparation II was more potent against pan¬ creatic trypsin, and was able to inhibit the TLE-activity only when dialysed acrosomal preparation or spermatozoa in low concentrations were used as the source of the enzyme.
DISCUSSION
The results confirm the earlier report by Haendle et al. (1965) of the presence in high concentration of a trypsin inhibitor in human and bovine seminal plasma. The method used for the separation of seminal plasma and spermatozoa produced preparations free from cytoplasmic-droplets, as had been reported by Dott & Dingle (1968 (Haendle et al., 1965; Fritz et al., 1968) (Fritz et al., 1968) . The inhibitory effect of the preparation III cannot depend on the presence of salts, amino acids or other low molecular weight substances, because preparation III could be concentrated by membrane ultrafiltration without any distinct loss of inhibitor capacity.
The ability of bull, rabbit and human seminal plasma to inhibit acrosomal TLE-activity has been reported earlier (von Waldschmidt et al., 1966; Zaneveld et al., 1969; Zaneveld, Srivastava & Williams, 1970; Suominen et al., 1970) . In the present study, both human and bull acrosomal TLE-activity could be evoked by repeated washings of the ejaculated spermatozoa with an electrolyte solution. This could have been due to removal of the inhibitor (s) from acrosomal TLE or could be due to a change in the permeability of the outer acrosomal or plasma membrane for the substrate. Both of the inhibitor preparations were able to inhibit the TLE-activity in intact spermatozoa as well as in the acroso¬ mal preparation. Preparation II, however, was able to inhibit TLE only when dialysed acrosomal preparation or spermatozoa in low concentrations were used as the enzyme source. It is probable, therefore, that the acrosomal TLE can be activated in intact spermatozoa by removing the inhibitor (s) which seem to be rather firmly attached to the spermatozoa (acrosomes).
The attachment of enzyme inhibitors to spermatozoa may be connected with the capacitation phenomenon (Austin, 1951; Chang, 1951 Chang, , 1957 which may involve a dissociation of enzyme-inhibitor-complexes between acrosomal hydrolases and seminal inhibitors. The successful capacitation of spermatozoa in 'unphysiological' conditions (Barros, 1968; Abney & Williams, 1969; Yanagimachi, 1969) could be explained on this hypothesis, and also the remedial effect on capacitation of some odd treatments, e.g. the effect of oestrogens which may undergo pH-changes in the female reproductive tract and these, in turn, could affect the enzyme-inhibitor-complex. Recently, Stambaugh, Brackett & Mastroianni (1969) and Zaneveld, Robertson, Kessler, Srivastava & Williams (1970) demonstrated that fertilization in vitro and in vivo, respectively, can be inhibited by trypsin inhibitors.
